Tvardi Therapeutics, Inc. TVRD
0.95 USD -0.09 (-9.03%)
Regular-session close
0.90 -0.05 -4.87%
Pre-market · Nov 20, 4:00 AM ET
0.9178 Day range 1.08
0.773 52-week range 5.69
- YTD
- -78.00%
- 1 year
- -75.93%
No chart data for this range yet.
- Market cap
- 12.64M
- EPS (ttm)
- -2.69
- YTD return
- -78.00%
- 1-year return
- -75.93%
- Volume
- 75.31K
- Avg volume
- 236.79K
- Open
- 1.06
- Previous close
- 1.04
- Day's range
- 0.9178 – 1.08
- 52-week range
- 0.773 – 5.69
Fundamental scorecard
5 of 25 checks passed on TVRD’s reported financials
5of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
TVRD Revenue — quarterly 0
TVRD Net income — quarterly -6.12M
TVRD EPS — quarterly -0.48
News
Tvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback Oppenheimer Maintains Outperform on Tvardi Therapeutics, Lowers Price Target to $9
Tvardi Therapeutics Q3 EPS $(0.48) Beats $(0.53) Estimate
Tvardi Therapeutics Announces Third Quarter 2026 Results and Provides Business Update
12 Health Care Stocks Moving In Monday's After-Market Session Chardan Capital Initiates Coverage On Tvardi Therapeutics with Buy Rating, Announces Price Target of $8
Your note
Sign in to keep a note on TVRD — it syncs with the Stock Master app.
